Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CERS · against 596 other Healthcare companies listed in US-listed
Ranked #486 of 597 · scores higher than 19% of peers · safety percentile 12
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)76 peers with a safety percentile of 10–19, including CERS · Click a bar to see the companies
Mainly because of its beta, debt / equity and current ratio, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | CERS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 523 reported | 1.09× | 0.23× | 18% | 33% | |
| BetaLower is better · 556 reported | 1.85 | 0.95 | 14% | 33% | |
| Current ratioHigher is better · 600 reported | 1.83× | 3.91× | 26% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 482 | 5.8B USD | 12 | 38 | |
| 483 | 201M USD | 12 | 24 | |
| 484 | 21.4B USD | 12 | 67 | |
| 485 | 1.6B USD | 12 | 29 | |
| 486 | 472M USD | 12 | 33 | |
| 487 | 966M USD | 12 | 33 | |
| 488 | 13.8B USD | 12 | 54 | |
| 489 | 1.1B USD | 12 | 32 | |
| 490 | 1.9B USD | 11 | 38 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score